# OX Alpha task: round60_batch2

- Timestamp: 2026-08-22T00:49:56.228979+00:00
- Model: stealth/ox-alpha
- Elapsed: 39.04s
- Finish reason: stop
- Usage: {"prompt_tokens": 4658, "completion_tokens": 1332, "total_tokens": 5990, "cost": 0, "is_byok": false, "prompt_tokens_details": {"cached_tokens": 576, "cache_write_tokens": 0, "audio_tokens": 0, "video_tokens": 0}, "cost_details": {"upstream_inference_cost": 0, "upstream_inference_prompt_cost": 0, "upstream_inference_completions_cost": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "image_tokens": 0, "audio_tokens": 0}}

## User prompt

```
You are performing CE-014 prior art analysis for the CTO. This is BATCH 2 of 3. The CTO must decide whether to KILL or PROMOTE a Slot 5 candidate based on whether any of 9 fetched patents constitutes blocking prior art. This batch contains 3 patents.

CANDIDATE CLAIM UNDER TEST:
A method for guiding endovascular stroke treatment comprising:
(a) during the procedure, measuring a physical signature of thrombus material
    retrieved in a first retrieval pass using a sensor integrated with the
    retrieval system;
(b) computing, from said signature together with intra-procedural procedural
    features (reperfusion grade, pass count, device trajectory), a calibrated
    risk score for symptomatic intracranial hemorrhage and 90-day functional
    outcome available before procedure completion;
(c) and gating a continuation/escalation decision — whether to perform
    additional retrieval passes or adjunct therapy — on said score.

BLOCKING TEST: A prior art patent BLOCKS the candidate if and only if its
claims (independently or in combination with another cited prior art under
KSR-style obviousness reasoning) read on ALL THREE elements (a), (b), (c)
of the candidate claim:

(a) INTRA-PROCEDURAL retrieved-clot PHYSICAL signature measurement
    — signal source must be a physical measurement of retrieved thrombus
      (NOT pre-procedural imaging; NOT post-procedural histology; NOT
      intra-procedural imaging of the vasculature without retrieved clot)
    — timing must be DURING the procedure (before procedure completion)

(b) Computing a risk score from said signature + intra-procedural procedural
    features (reperfusion grade, pass count, device trajectory) — for sICH
    AND/OR 90-day functional outcome

(c) Gating a CONTINUATION/ESCALATION decision on said score
    — decision must be whether to perform additional retrieval passes or
      adjunct therapy (NOT a pre-procedural treatment-selection decision;
      NOT a post-procedural triage decision; NOT a notification/workflow
      decision)

If a patent hits (a) and (b) but NOT (c), it is NON-BLOCKING.
If a patent hits (b) and (c) but uses a different signal source than (a),
it is NON-BLOCKING.
If a patent hits (a) and (c) but uses a different score computation than (b),
it is NON-BLOCKING.
Only if a patent hits ALL THREE (a)+(b)+(c) is it BLOCKING.

Under KSR obviousness, a patent may ALSO be blocking if it would be obvious
to combine its teaching with another cited patent's teaching to produce all
three elements. Note this separately as "blocking-via-combination" if so.

THE 3 PATENTS IN THIS BATCH:

===== PATENT 1: US20210361314A1 =====
Title: Aspiration Thrombectomy System and Methods for Thrombus Removal with Aspiration Catheter
URL: https://patents.google.com/patent/US20210361314A1/en
Original concern: HIGH — 'Aspiration Thrombectomy System ... reinforcement learning to further improve prediction accuracy'.
Abstract:
Abstract An aspiration thrombectomy system, comprising a vacuum source comprising a controllable vacuum valve, a pressure source comprising a controllable pressure valve, an aspiration catheter having a proximal end and a distal end, wherein the proximal end of the aspiration catheter comprises connection tubing having a lumen configured to accommodate fluid, and wherein the connection tubing acts as a common conduit for fluid communication between the aspiration catheter and the vacuum and pressure sources via the vacuum and pressure valves, respectively, and a controller configured to open and close the vacuum and vent valves in a predetermined cycle to change a level of vacuum at the distal end of the aspiration catheter and control flow in and out from the distal end of the catheter.

Claims (extracted, may be truncated):
Claims ( 16 ) 1 . An aspiration thrombectomy system, comprising: a vacuum source comprising a controllable vacuum valve; a pressure source comprising a controllable pressure valve; an aspiration catheter having a proximal end and a distal end, wherein the proximal end of the aspiration catheter comprises connection tubing having a lumen configured to accommodate fluid, and wherein the connection tubing acts as a common conduit for fluid communication between the aspiration catheter and the vacuum and pressure sources via the vacuum and pressure valves, respectively; and a controller configured to open and close the vacuum and vent valves in a predetermined cycle to change a level of vacuum at the distal end of the aspiration catheter and control flow in and out from the distal end of the catheter. 2 . The aspiration thrombectomy system of claim 1 , wherein the fluid is one or more of saline or blood. 3 . The aspiration thrombectomy system of claim 1 , further comprising: a three-way joint comprising the pressure valve, the vacuum valve, and at least a portion of the connection tubing in fluid communication with the aspiration catheter; and an external unit in fluid communication with the aspiration catheter and the three-way joint, wherein the external unit is in fluid communication with the aspiration catheter and the vacuum source. 4 . The aspiration thrombectomy system of claim 1 , wherein the pre-determined cycle includes one or more time periods of a double-closed state in which both the pressure and vacuum valves are closed. 5 . The aspiration thrombectomy system of claim 4 , wherein each of the one or more time periods of the double-closed state is no greater than 30 ms. 6 . The aspiration thrombectomy system of claim 1 , wherein the pre-determined cycle includes one or more time periods of a pressure-only state in which the vacuum valve is closed and the pressure valve is open. 7 . The aspiration thrombectomy system of claim 6 , wherein each of the one or more time periods of the pressure-only state is no greater than 50 ms. 8 . The aspiration thrombectomy system of claim 1 , wherein the controller is configured to repeatedly and periodically open and close the vacuum and pressure valves in the predetermined cycle. 9 . The aspiration thrombectomy system of claim 1 , wherein the controller is configured to selectively open and close the pressure and vacuum valves in a repeated cycle comprising: a vacuum-only state in which the vacuum valve is open and the pressure valve is closed; a first double-closed state in which the vacuum valve is closed and the pressure valve is closed; a pressure-only state in which the vacuum valve is closed and the pressure valve is open; and a second double-closed state in which the vacuum valve is closed and the pressure valve is closed. 10 . The aspiration thrombectomy system of claim 9 , wherein a time between an opening of the pressure valve and a closing of the pressure valve is between approximately 10 ms and approximately 50 ms. 11 . The aspiration thrombectomy system of claim 1 , wherein the controller is configured to selectively open and close the pressure and vacuum valves in a repeated cycle comprising: a vacuum-only state in which the vacuum valve is open and the pressure valve is closed; followed by a first double-closed state in which the vacuum valve is closed and the pressure valve is closed; followed by a pressure-only state in which the vacuum valve is closed and the pressure valve is open; and followed by a second double-closed state in which the vacuum valve is closed and the pressure valve is closed. 12 . The aspiration thrombectomy system of claim 11 , wherein a time period of the first double-closed state is no greater than 30 ms. 13 . The aspiration thrombectomy system of claim 1 , wherein the controller is configured to substantially control flow in and out from the distal end of the catheter by regulating a timing of the pressure valve. 14 . The aspiration thrombectomy system of claim 1 , wherein the controller is configured to control one or more valves associated with the aspiration thrombectomy system. 15 . The aspiration thrombectomy system of claim 1 , wherein the controller is an electronic controller. 16 . The aspiration thrombectomy system of claim 1 , wherein the vacuum and pressure valves are driven by cam follower actuators.

------------------------------------------------------------

===== PATENT 2: US8374414B2 =====
Title: Method and system for detecting ischemic stroke
URL: https://patents.google.com/patent/US8374414B2/en
Original concern: MEDIUM — Viz.ai 'Method and system for detecting ischemic stroke'.
Abstract:
Abstract A method for assisting diagnosis of stroke by image analysis, the method comprising obtaining a scanned brain image of a patient, transforming the scanned brain image into a digitized brain image, removing bone and other artifacts from the digitized brain image, generating at least one circular adaptive region of interest on one side of the brain image, generating a binary mask of the circular adaptive region of interest, calculating the percentage of zeros from the binary mask within the circular adaptive region of interest, locating at least one corresponding circular adaptive region of interest on the other side of the brain image, and comparing the circular adaptive region of interest with the corresponding circular adaptive region on interest of the other side of the brain based on a plurality of texture attributes.

Claims (extracted, may be truncated):
Claims ( 17 ) 1. A method for assisting diagnosis of stroke by image analysis, the method comprising: obtaining a scanned brain image of a patient; transforming the scanned brain image into a digitized brain image; removing bone and other artifacts from the digitized brain image; generating at least one circular adaptive region of interest with a center (X c , Y c ) and radius r on one side of the brain image; generating a binary mask of the circular adaptive region of interest; calculating the percentage of zeros (P 0 ) from the binary mask within the circular adaptive region of interest; increasing the radius of the circular adaptive region of interest if P 0 is greater than a cutoff value; locating at least one corresponding circular adaptive region of interest on the other side of the brain image; and comparing the circular adaptive region of interest with the corresponding circular adaptive region on interest of the other side of the brain based on a plurality of texture attributes. 2. The method of claim 1 , wherein the scanned image of the brain is a computed tomography image. 3. The method of claim 1 , further comprises aligning the digitized brain image. 4. The method of claim 1 , wherein the plurality of texture attributes are calculated based on grey level co-occurrence matrix, the texture attributes include energy, entropy, inverse difference moment, inertia, shade, prominence, correlation, and variance. 5. The method of claim 1 , wherein locating the corresponding circular adaptive region of interest on the other side of the brain is performed by gray level co-occurrence matrix. 6. The method of claim 1 , wherein removing bone and other artifacts from the digitized brain image includes removing regions of calcifications that have fewer than 500 square pixels. 7. The method of claim 1 , wherein the brain image is determined as abnormal based on a Feature-Based Index (FBI), if FBI→0, FBI→∞, and FBI →1, where FBI = L R , and ⁢ ⁢ FBI _ = L ⁢ \ ⁢ { l } R ⁢ \ ⁢ { r } , where L is texture attributes of a left side of the scanned brain image, R is texture attributes of a right side of the scanned brain images, l is texture attributes of the circular adaptive region of interest on the left, and r is texture attributes of a right side of the circular adaptive region of interest on the right side. 8. The method of claim 1 , wherein the brain image shows brain anterior cerebral artery (ACA), middle cerebral artery (MCA), and posterior cerebral artery (PCA), and basal ganglia of the patient. 9. A system for assisting diagnosis of stroke by image analysis, comprising: an image capture device configured to obtain a scanned brain image of a patient, transform the scanned brain image into a digitized brain image, and transmit the digitized brain image; an image analyzing unit configured to receive the digitized brain image, remove bone and other artifacts from the digitized brain image, generate at least one circular adaptive region of interest with a center (X c , Y c ) and radius r on one side of the brain image, generating a binary mask of the circular adaptive region of interest, calculating the percentage of zeros (P 0 ) from the binary mask within the circular adaptive region of interest, increase the radius of the circular adaptive region of interest if P 0 is greater than a cutoff value, locating at least one corresponding circular adaptive region of interest on the other side of the brain image, and compare the circular adaptive region of interest with the corresponding circular adaptive region on interest of the other side of the brain based on a plurality of texture attributes. 10. A non-transitory computer-readable storage medium storing a computer program that causes a computer to execute a method for assisting diagnosis of stroke by image analysis, comprising: obtaining a scanned brain image of a patient; transforming the scanned brain image into a digitized brain image; removing bone and other artifacts from the digitized brain image; generating at least one circular adaptive region of interest with a center (X c , Y c ) and radius r on one side of the brain image; generating a binary mask of the circular adaptive region of interest; calculating the percentage of zeros (P 0 ) from the binary mask within the circular adaptive region of interest; increasing the radius of the circular adaptive region of interest if P 0 is greater than a cutoff value; locating at least one corresponding circular adaptive region of interest on the other side of the brain image; and comparing the circular adaptive region of interest with the corresponding circular adaptive region on interest of the other side of the brain based on a plurality of texture attributes. 11. The non-transitory computer-readable storage medium storing the computer program that causes the computer to execute the method of claim 10 , wherein the scanned image of the brain is a computed tomography image. 12. The non-transitory computer-readable 

------------------------------------------------------------

===== PATENT 3: WO2011148015A1 =====
Title: Method for the prognosis of cerebral ischemia
URL: https://patents.google.com/patent/WO2011148015A1/en
Original concern: MEDIUM — 'Method for the prognosis of cerebral ischemia'.
Abstract:
Abstract The invention relates to a method for the prognosis of cerebral ischemia and is based on observing the patient and analyzing variables. Said invention establishes a novel prognostic marker on the basis of measuring the levels of the enzymes glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT).

Claims (extracted, may be truncated):
Claims Translated from Spanish Reivindicaciones Claims 1. Procedimiento para pronosticar la isquemia cerebral, que comprende &nbsp;1. Procedure for predicting cerebral ischemia, which includes i) medir en una muestra de un paciente la concentración de las enzimas enzima glutamato oxalacetato transaminasa (GOT), y glutamato piruvato transaminasa (GPT), &nbsp;i) measure in a sample of a patient the concentration of the enzymes glutamate oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase (GPT), ii) comparar la concentración de GOT y GPT con el valor de punto de corte establecido, &nbsp;ii) compare the concentration of GOT and GPT with the set cut-off value, de forma que cuando las concentraciones de GOT y GPT sean superiores o iguales al valor del punto de corte, entonces el paciente presenta una predisposición favorable para un buen pronóstico, y cuando las concentraciones de GOT y GPT sean inferiores al valor del punto de corte el paciente presenta una predisposición favorable para un mal pronóstico. so that when the GOT and GPT concentrations are greater than or equal to the cut-off point value, then the patient presents a favorable predisposition for a good prognosis, and when the GOT and GPT concentrations are lower than the cut-off point value, the patient has a favorable predisposition for a poor prognosis. 2. Procedimiento según la reivindicación 1, donde el punto de corte para le GOT es 24 mU/mL y para la GPT es 21 mU/mL. &nbsp;2. Method according to claim 1, wherein the cut-off point for the GOT is 24 mU / mL and for the GPT it is 21 mU / mL. 3. Procedimiento según las reivindicaciones 1 y 2, donde la muestra es de sangre o suero. &nbsp;3. Method according to claims 1 and 2, wherein the sample is blood or serum. 4. Procedimiento según las reivindicaciones anteriores, donde el paciente es humano. &nbsp;4. Method according to the preceding claims, wherein the patient is human. 5. Procedimiento según las reivindicaciones anteriores, donde el paciente sufrió previamente un episodio de ictus isquémico. 5. Procedure according to the preceding claims, wherein the patient previously suffered an episode of ischemic stroke. 6. Procedimiento según las reivindicaciones anteriores, donde el paciente sufrió un episodio de ictus isquémico entre 2 y 4 meses antes. &nbsp;6. Procedure according to the preceding claims, wherein the patient suffered an episode of ischemic stroke between 2 and 4 months earlier. 7. Procedimiento según las reivindicaciones anteriores, donde el paciente sufrió un episodio de ictus isquémico 3 meses antes. &nbsp;7. Procedure according to the preceding claims, wherein the patient suffered an episode of ischemic stroke 3 months before.

------------------------------------------------------------

YOUR ANALYSIS — for EACH of the 3 patents in this batch, produce this structured assessment:

PATENT: <id>
  ELEMENT (a) hit? YES / NO / PARTIAL — quote the claim language that supports this
  ELEMENT (b) hit? YES / NO / PARTIAL — quote the claim language that supports this
  ELEMENT (c) hit? YES / NO / PARTIAL — quote the claim language that supports this
  BLOCKING VERDICT: BLOCKING / NON-BLOCKING / BLOCKING-VIA-COMBINATION
  If BLOCKING or BLOCKING-VIA-COMBINATION: state the exact combination that produces all three elements
  If NON-BLOCKING: state which element(s) miss and why

CONSTRAINTS:
- Quote ACTUAL claim language from the patents above. Do NOT fabricate claim language.
- If the extracted claims are truncated or missing, state that explicitly and mark the assessment INCONCLUSIVE.
- Be adversarial: try to find a blocking interpretation. The CTO wants to KILL the candidate if any blocking prior art exists.
- Do NOT make the strategic KILL/PROMOTE decision — that is the CTO's role.

OUTPUT FORMAT: Plain text, no emojis, structured per patent. Target ~800-1200 words total for this batch.

```

## Response

PATENT: US20210361314A1
  ELEMENT (a) hit? NO. The claims are directed entirely to an aspiration system's valve cycling mechanics. Claim 1: "a controller configured to open and close the vacuum and vent valves in a predetermined cycle to change a level of vacuum at the distal end of the aspiration catheter." There is no claim language reciting measurement of a physical signature of retrieved thrombus material. No sensor on the retrieval system for thrombus characterization appears in the extracted claims.
  ELEMENT (b) hit? NO. No claim language computes any risk score, references sICH, functional outcome, reperfusion grade, pass count, or device trajectory. The only computation is valve timing control ("predetermined cycle," "double-closed state... no greater than 30 ms").
  ELEMENT (c) hit? NO. No continuation/escalation decision gating is claimed; the controller controls aspiration flow, not treatment decisions.
  BLOCKING VERDICT: NON-BLOCKING
  Misses all three elements. Note: the original concern cited "reinforcement learning to further improve prediction accuracy" — that language does NOT appear in the extracted claims above. If it exists in the description (not claims), it could at most support a KSR combination argument, but a description-only mention cannot independently block. Claims may be truncated in extraction, but all 16 independent/dependent claims shown are valve-cycle apparatus claims with no sensing or scoring limitation.

PATENT: US8374414B2
  ELEMENT (a) hit? NO. Signal source is pre-procedural/diagnostic brain imaging, not retrieved thrombus. Claim 1: "obtaining a scanned brain image of a patient... wherein the scanned image of the brain is a computed tomography image" (claim 2). This is explicitly excluded by the blocking test: pre-procedural imaging of vasculature/brain, not a physical measurement of retrieved clot during the procedure.
  ELEMENT (b) hit? PARTIAL. It computes an abnormality index from texture attributes — claim 7: "the brain image is determined as abnormal based on a Feature-Based Index (FBI)" comparing left/right hemisphere texture attributes. However, this is a diagnostic detection score, not a calibrated risk score for sICH or 90-day functional outcome computed from intra-procedural procedural features (reperfusion grade, pass count, trajectory).
  ELEMENT (c) hit? NO. No continuation/escalation decision is claimed. The method is "for assisting diagnosis of stroke" — a pre-treatment detection/triage function, explicitly excluded by the blocking test.
  BLOCKING VERDICT: NON-BLOCKING
  Misses (a) entirely (wrong signal source), misses (c) (diagnosis, not intra-procedural escalation gating), and only partially touches (b) with a different score type. Even under KSR combination reasoning, this patent teaches CT-image texture analysis for stroke detection — combining it would still require importing both a retrieved-clot sensor and an escalation-gating step from elsewhere, which no other patent in this batch supplies.

PATENT: WO2011148015A1
  ELEMENT (a) hit? NO. Signal source is blood/serum biomarkers, not retrieved thrombus. Claim 1: "medir en una muestra de un paciente la concentración de las enzimas... GOT, y GPT" / "measure in a sample of a patient the concentration of the enzymes glutamate oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase (GPT)." Claim 3: "la muestra es de sangre o suero" / "the sample is blood or serum." A blood draw is not a physical signature measurement of retrieved thrombus material via a sensor integrated with the retrieval system.
  ELEMENT (b) hit? PARTIAL. It produces a prognosis output — claim 1: "cuando las concentraciones de GOT y GPT sean superiores o iguales al valor del punto de corte, entonces el paciente presenta una predisposition favorable para un buen pronóstico" (good vs. poor prognosis based on cut-off comparison). But this is a binary cut-off classification from two lab values, not a calibrated risk score computed from a thrombus signature plus intra-procedural procedural features. Timing context in claims 5-7 suggests post-stroke sampling (2-4 months prior episodes), i.e., retrospective prognostication, not intra-procedural.
  ELEMENT (c) hit? NO. No claim language gates any continuation/escalation decision — no additional retrieval passes, no adjunct therapy decision. Purely prognostic.
  BLOCKING VERDICT: NON-BLOCKING
  Misses (a) (blood biomarker, not retrieved-clot physical signature), misses (c) (no escalation gating), and only partially matches (b) with a different computation basis. Under KSR, combining this with US20210361314A1 (aspiration hardware) or US8374414B2 (imaging) would still not yield element (a): none of the three teaches measuring a physical signature of retrieved thrombus with an integrated sensor, nor gating additional passes on such a measurement.

BATCH SUMMARY:
- All 3 patents NON-BLOCKING as standalone references.
- Blocking-via-combination analysis: No combination among these three produces element (a). None discloses a sensor integrated with a retrieval system measuring a physical property of retrieved thrombus during the procedure. Element (c) is likewise absent from all three. The strongest adversarial combination (US8374414B2 scoring + WO2011148015A1 prognosis framing + US20210361314A1 thrombectomy apparatus) fails because each contributes neither a retrieved-clot physical measurement nor an intra-procedural escalation gate.
- Caveat: extracted claims for US20210361314A1 appear complete (16 claims); US8374414B2 claims are truncated after claim 12; WO2011148015A1 claims appear complete (7 claims). Truncation in US8374414B2 is unlikely to change the verdict given its consistent imaging-diagnosis character, but formally the assessment for that patent carries minor truncation uncertainty.

Recommendation to CTO: evidence in this batch supports PROMOTE consideration; final decision rests with you.
